BPC-157, KPV, TB-500, and GHK-Cu working together to target healing, inflammation, and cellular renewal from four different angles at once. This isn't a supplement stack -- it's a precision protocol.
KLOW is a multi-peptide blend formulated to address healing, inflammation, tissue repair, and cellular renewal simultaneously. Instead of targeting one pathway at a time, KLOW combines four clinically studied peptides into a single subcutaneous injection protocol.
Each component works on a different mechanism -- gut healing, tissue repair, anti-inflammation, collagen remodeling -- but they converge toward the same goal: getting your body's repair systems back online and running at full capacity.
Brittany prescribes KLOW through a licensed 503A compounding pharmacy with individualized dosing based on your labs, goals, and health history. This is a real prescription, not a grey-market product.
Each peptide in the KLOW blend serves a distinct role. Together, they create a coordinated regenerative signal that's greater than the sum of its parts.
A pentadecapeptide originally derived from gastric proteins. BPC-157 supports gut lining integrity, connective tissue repair, and angiogenesis (new blood vessel formation). It's one of the most clinically studied healing peptides and serves as the foundation of the KLOW blend.
A tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). KPV works directly inside the cell nucleus to inhibit NF-kB and MAPK -- two master switches that control chronic inflammation. This is the "calm down" signal in the blend.
A synthetic analog of thymosin beta-4, a protein involved in cell migration, new vessel formation, and organized wound repair. TB-500 has systemic distribution -- it doesn't just work locally. It travels to wherever the body needs repair support.
A naturally occurring copper-binding tripeptide found in human plasma. GHK-Cu drives collagen production, remodels the extracellular matrix, and breaks down damaged collagen so healthy tissue can replace it. The anti-aging and skin quality component of the blend.
KLOW targets patients who are dealing with stubborn healing, chronic inflammation, or accelerated aging that hasn't responded to single-agent approaches.
Joint pain, gut issues, autoimmune flares, or systemic inflammation that won't resolve. KLOW's KPV and BPC-157 hit inflammation from both the signaling and barrier-integrity sides.
Post-surgical healing, sports injuries, tendon/ligament repair, or slow-healing wounds. TB-500 and BPC-157 together accelerate tissue repair from two directions.
Leaky gut, IBS, food sensitivities, or gut lining damage. BPC-157 supports gut barrier integrity while KPV calms the inflammation driving the damage cycle.
Loss of skin elasticity, poor wound healing, and systemic repair slowdown. GHK-Cu drives collagen production and matrix remodeling for whole-body cellular renewal.
After surgery, aesthetic procedures, or dental work. KLOW supports faster, cleaner healing by activating repair from multiple pathways simultaneously.
Proactive patients investing in cellular health and repair capacity before problems show up. GHK-Cu and BPC-157 support long-term tissue quality and resilience.
Each peptide addresses a different link in the repair chain. Together, they create a coordinated signal that covers the full cycle from damage to renewal.
KPV shuts down the NF-kB inflammatory cascade at the nuclear level, stopping the damage loop before repair can begin.
BPC-157 restores gut lining and connective tissue integrity, sealing the leaks that let inflammation spread.
TB-500 promotes cell migration and new vessel formation, getting repair resources to where they're needed -- systemically.
GHK-Cu drives collagen production and breaks down damaged matrix, replacing old tissue with new. The renewal phase.
KLOW is the brand name for a specific 4-peptide blend containing BPC-157, KPV, TB-500, and GHK-Cu. The name refers to the blend itself rather than being an acronym. It's formulated so that all four components can be delivered in a single daily subcutaneous injection rather than managing multiple separate peptide protocols.
Single-peptide protocols target one pathway. KLOW targets four simultaneously: inflammation control (KPV), barrier repair (BPC-157), systemic tissue repair (TB-500), and collagen remodeling (GHK-Cu). The components are synergistic -- for example, KPV calms the inflammation that's damaging tissue while BPC-157 rebuilds the damaged tissue. You're addressing the full repair cycle rather than one piece of it. It also simplifies dosing: one injection per day instead of managing multiple vials and schedules.
Most patients begin noticing changes within the first 2-3 weeks -- particularly with inflammation reduction, sleep quality, and general energy. Tissue repair and gut healing benefits typically become more apparent in weeks 4-6. Collagen remodeling and skin quality improvements from GHK-Cu are more gradual and compound over the full 8-week protocol and beyond. Every patient's timeline varies based on what we're targeting and your starting point.
Yes. Brittany requires baseline labs before prescribing any peptide protocol. This ensures KLOW is appropriate for you, helps us identify what we're targeting, and gives us data to measure your progress against. If you don't have recent labs, we can order them through the clinic at cost.
Yes, and it's a popular combination. Many patients on semaglutide or tirzepatide experience GI side effects and tissue changes during weight loss. KLOW's BPC-157 supports gut lining integrity while GHK-Cu helps maintain skin elasticity and collagen production during body composition changes. Brittany evaluates each case individually to make sure the timing and dosing work together safely.
KLOW is well-tolerated by most patients when prescribed and monitored by a licensed provider. The most common side effect is mild injection site irritation (redness, slight itch) that resolves within an hour. Some patients report mild fatigue during the first few days as the body's repair processes ramp up. Serious adverse effects are rare. Brittany monitors your progress throughout the protocol and adjusts dosing if needed.
KLOW arrives as a lyophilized (freeze-dried) powder that you reconstitute with bacteriostatic water. Once mixed, it's stored in the refrigerator. You self-administer a subcutaneous injection daily -- typically in the abdominal area, similar to insulin. Brittany walks you through the reconstitution process, injection technique, and dosing at your initial visit. Most patients are comfortable doing it on their own after the first session.
Brittany prescribes KLOW through a licensed 503A compounding pharmacy. This means the blend is made to order based on a valid prescription from a licensed provider -- not purchased off the shelf from a grey-market website. 503A pharmacies are regulated, inspected, and held to pharmaceutical compounding standards. You're getting a real Rx product with verified purity and potency.
Explore our full peptide menu -- BPC-157, Sermorelin, CJC-1295/Ipamorelin, NAD+, and more. Each protocol is customized to your goals.
View Peptide TherapySupport your KLOW protocol with IV hydration, glutathione, and vitamin infusions for enhanced systemic delivery and recovery.
View IV MenuCombining KLOW with semaglutide or tirzepatide? BPC-157 supports gut health while GHK-Cu helps maintain skin quality during weight loss.
Weight Loss ProgramBook a consultation with Brittany to review your labs, discuss your goals, and find out if KLOW is the right protocol for you. Real provider, real Rx, real results.
